UTI (UTI) director Srere sells 15,000 shares at $36.59 average price
Rhea-AI Filing Summary
UNIVERSAL TECHNICAL INSTITUTE INC director Linda J. Srere sold shares in an open-market transaction. On May 11, 2026, she sold 15,000 shares of common stock at a weighted average price of $36.5867 per share. After this sale, she directly owns 127,564 shares, indicating she retained a substantial position in the company.
Positive
- None.
Negative
- None.
Insights
Director executes open-market sale of 15,000 UTI shares, retaining a sizable stake.
Director Linda J. Srere completed an open-market sale of 15,000 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock at a weighted average price of $36.5867 per share on May 11, 2026.
The transaction is coded as an open-market sale, a strong-signal insider action, but she continues to hold 127,564 shares directly. The sale represents a portion of her position rather than a full exit, which is consistent with portfolio rebalancing or liquidity actions.
The footnote notes a weighted average price across multiple trades in a range of $36.52 to $37.32. Subsequent filings may provide additional context if trading activity continues, but this single transaction alone does not clearly alter the broader investment thesis.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock, $0.0001 par value | 15,000 | $36.5867 | $549K |
Footnotes (1)
- [object Object]
Key Figures
Key Terms
open-market sale financial
weighted average price financial
non-derivative financial
Form 4 regulatory
FAQ
What did UTI director Linda J. Srere report in this Form 4 transaction?
Director Linda J. Srere reported an open-market sale of 15,000 shares of UNIVERSAL TECHNICAL INSTITUTE INC common stock. The transaction involved non-derivative common shares with a $0.0001 par value, reflecting a direct reduction in her shareholdings.
What type of insider transaction is disclosed for UTI in this Form 4?
The Form 4 discloses a non-derivative open-market sale of common stock, coded as “S”. The transaction direction is classified as sell, distinguishing it from option exercises, gifts, or tax-withholding entries that often appear in other insider filings.
Does the UTI Form 4 footnote provide details about the trade pricing?
Yes. The footnote states that the reported price is a weighted average, with individual trades executed at prices between $36.52 and $37.32. It notes that detailed trade breakdowns are available to the issuer or regulators upon request.